Glycopeptide and daptomycin resistance in community-associated MRSA in the UK

Infection

Volumn 39, Issue 3, 2011, Pages 277-279

  Kirby, A ^a   Edwards, C ^b   Broughton, C M ^a   Williams, N J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE REPLACEMENT; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; UNITED KINGDOM;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GLYCOPEPTIDES; GREAT BRITAIN; GUIDELINES AS TOPIC; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 79961167735     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0103-y     Document Type: Article

References (15)

1. BC Millar BD Prendergast JE Moore 2008 Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis J Antimicrob Chemother 61 1 1 7 17962214 10.1093/jac/dkm410 1:CAS:528:DC%2BD1cXhtFWhtQ%3D%3D
2. JM Andrews 2008 BSAC standardized disc susceptibility testing method (version 7) J Antimicrob Chemother 62 2 256 278 18474513 10.1093/jac/dkn194 1:CAS:528:DC%2BD1cXosVOgsLo%3D (Pubitemid 351984768)
3. G Lina Y Piemont F Godail-Gamot M Bes MO Peter V Gauduchon, et al. 1999 Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia Clin Infect Dis 29 5 1128 1132 10524952 10.1086/313461 1:STN:280:DyaK1MvlsVKntA%3D%3D (Pubitemid 30265628)
4. CK Shutt JI Pounder SR Page BJ Schaecher GL Woods 2005 Clinical evaluation of the DiversiLab microbial typing system using repetitive-sequence- based PCR for characterization of Staphylococcus aureus strains J Clin Microbiol 43 3 1187 1192 15750081 10.1128/JCM.43.3.1187-1192.2005 1:CAS:528: DC%2BD2MXjtVGjs7g%3D (Pubitemid 40364936)
5. MJ Ellington C Perry M Ganner M Warner I McCormick Smith RL Hill, et al. 2009 Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales Eur J Clin Microbiol Infect Dis 28 9 1113 1121 19484277 10.1007/s10096-009-0757-x 1:STN:280:DC%2BD1MnmtVOrsg%3D%3D
6. S Murchan ME Kaufmann A Deplano R de Ryck M Struelens CE Zinn, et al. 2003 Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains J Clin Microbiol 41 4 1574 1585 12682148 10.1128/JCM.41.4.1574-1585.2003 1:CAS:528: DC%2BD3sXjsVOnu7g%3D (Pubitemid 36428107)
7. B Perichon P Courvalin 2009 VanA-type vancomycin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 11 4580 4587 19506057 10.1128/AAC.00346-09 1:CAS:528:DC%2BD1MXhtl2itLvF
8. van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature. Eur J Clin Microbiol Infect Dis. 2010. doi: 10.1007/s10096-010-1128-3
9. SJ van Hal DL Paterson 2011 Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates Antimicrob Agents Chemother 55 1 405 410 21078939 10.1128/AAC.01133-10
10. M Wootton RA Howe R Hillman TR Walsh PM Bennett AP MacGowan 2001 A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital J Antimicrob Chemother 47 4 399 403 11266410 10.1093/jac/47.4.399 1:CAS:528:DC%2BD3MXjtVamtLk%3D (Pubitemid 32303403)
11. PA Moise D North JN Steenbergen G Sakoulas 2009 Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions Lancet Infect Dis 9 10 617 624 19778764 10.1016/S1473-3099(09) 70200-2 1:CAS:528:DC%2BD1MXhtlCjtL%2FJ
12. BT Tsuji MJ Rybak CM Cheung M Amjad GW Kaatz 2007 Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents Diagn Microbiol Infect Dis 58 1 41 47 17300912 10.1016/j.diagmicrobio.2006.10.021 1:CAS:528:DC%2BD2sXlt1amtrw%3D (Pubitemid 46694261)
13. JC Hageman J Patel P Franklin K Miscavish L McDougal D Lonsway, et al. 2008 Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus Diagn Microbiol Infect Dis 62 4 440 442 18842378 10.1016/j.diagmicrobio.2008.08.005 1:CAS:528:DC%2BD1cXhsVWmsL7N
14. CJ Graber MK Wong HA Carleton F Perdreau-Remington BL Haller HF Chambers 2007 Intermediate vancomycin susceptibility in a community-associated MRSA clone Emerg Infect Dis 13 3 491 493 17552110 10.3201/eid1303.060960 1:CAS:528:DC%2BD2sXjvVOktrg%3D (Pubitemid 46348141)
15. JB Patel LA Jevitt J Hageman LC McDonald FC Tenover 2006 An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus Clin Infect Dis 42 11 1652 1653 16652325 10.1086/504084 1:CAS:528:DC%2BD28XlvVOrsrg%3D